Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGINTERVENTIONAL

Cognitive Behavioral Therapy for Sleep and Circadian Disturbances (CBT-I) in Treatment-Resistant Schizophrenia

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Using a randomized controlled design, the project aims to test if cognitive behavioral therapy interventions specifically targeting sleep disorders can significantly lessen the burden of the disrupted sleep in patients with treatment resistant schizophrenia (TRS) and by proxy lead to a reduction in psychotic symptoms and improvement in quality of life. We are including treatment-resistant patients with schizophrenia other nonorganic and chronic psychoses and in addition meeting the criteria of a sleep or circadian disorder. Included patients will be block randomized to either 8-10 sessions of CBT-I (active treatment) with a specific focus on sleep or 8-10 sessions of regularCBT with a specific focus on patients' psychopathology (treatment as usual) approx.1 session/week. After 12 weeks the full battery of assessments will be repeated forboth groups. Primary analyses will be to identify group-difference in changes using repeated measure ANOVA.

Who May Be Eligible (Plain English)

Who May Qualify: - Diagnosed with ICD-10 schizophrenia (DF20), chronic paranoid psychosis (DF22), schizo-affective disorder (DF25) or other non-organic psychosis (DF28-DF29) - Treatment resistance according to TRRIP criteria - Sleeping difficulties (minimum duration 3 months) - ISI score \>14 - Stable psychopharmacological treatment the last month - Only legal competent patient can participant Who Should NOT Join This Trial: - Psychiatric admission last six months (more than 1 week or resulted in significant changes in psychopharmacological treatment) - Substance abuse to a degree that will interfere with participation. - Diagnoses of sleep apnea/CPAP use Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Diagnosed with ICD-10 schizophrenia (DF20), chronic paranoid psychosis (DF22), schizo-affective disorder (DF25) or other non-organic psychosis (DF28-DF29) * Treatment resistance according to TRRIP criteria * Sleeping difficulties (minimum duration 3 months) * ISI score \>14 * Stable psychopharmacological treatment the last month * Only legal competent patient can participant Exclusion Criteria: * Psychiatric admission last six months (more than 1 week or resulted in significant changes in psychopharmacological treatment) * Substance abuse to a degree that will interfere with participation. * Diagnoses of sleep apnea/CPAP use

Treatments Being Tested

OTHER

CBT-I

Cognitive therapy tailored for insomnia symptoms.

OTHER

CBT

Cognitive behavioral therapy for general psychopathology

Locations (1)

Mental Health Centre Glostrup
Glostrup, Denmark, Denmark